Meclizine (dihydrochloride)

Meclizine (Meclozine) dihydrochloride, an antihistamine, reversibly inhibits the interaction of histamine at the H1 receptors. Meclizine dihydrochloride is a member of the piperazine class of H1 antagonists. Meclizine dihydrochloride is an effective anti-motion sickness agent. Meclizine dihydrochloride crosses the blood-brain barrier. Meclizine dihydrochloride can be used for the research of polyQ toxicity disorders, such as Huntington's disease. Meclizine dihydrochloride is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for Human CAR[1][2][3].

Product Specifications

CAS Number

[1104-22-9]

Product Name Alternative

Meclozine (dihydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H361

Target

Apoptosis; Histamine Receptor

Type

Reference compound

Related Pathways

Apoptosis; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling

Applications

Cancer-programmed cell death

Field of Research

Neurological Disease; Endocrinology; Cancer

Assay Protocol

https://www.medchemexpress.com/Meclizine-dihydrochloride.html

Concentration

10mM

Purity

99.95

Solubility

DMSO : ≥ 33.33 mg/mL

Smiles

CC1=CC(CN2CCN(C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4)CC2)=CC=C1.Cl.Cl

Molecular Formula

C25H29Cl3N2

Molecular Weight

463.87

Precautions

H302, H361

References & Citations

[1]Priti N. Patel, et al. Safety and Efficacy in the Treatment and Prevention of Motion Sickness.|[2]Vishal M Gohil, et al. Meclizine is neuroprotective in models of Huntington's disease. Hum Mol Genet. 2011 Jan 15;20 (2) :294-300.|[3]Wendong Huang, et al. Meclizine Is an Agonist Ligand for Mouse Constitutive Androstane Receptor (CAR) and an Inverse Agonist for Human CAR|[4] Seiji Kishi, et al. Meclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury. EBioMedicine. 2015 Jul 29;2 (9) :1090-101.